Trial
NCT00493974
Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Minnesota
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Pulmonary Disease, Chronic Obstructive
Intervention
Zileuton
Why stopped
Lack of feasibility due to low recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-18